• 8450 Citations
  • 49 Scopus h-Index
1982 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where John A III Copland is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Neoplasms Medicine & Life Sciences
Tumors Chemical Compounds
Renal Cell Carcinoma Medicine & Life Sciences
Genes Chemical Compounds
Cells Chemical Compounds
Cell Line Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Atlases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2004 2017

Stearoyl-CoA Desaturase
Neoplasms
Therapeutics
Biological Availability
Survival
Neoplasms
rhoB GTP-Binding Protein
Paclitaxel
Apoptosis
Therapeutics
Transforming Growth Factor beta Receptors
Renal Cell Carcinoma
Transforming Growth Factor beta
Carcinogenesis
Gene Targeting

Research Output 1982 2020

Molecular inhibitor of QSOX1 suppresses tumor growth in vivo

Fifield, A. L., Hanavan, P. D., Faigel, D. O., Sergienko, E., Bobkov, A., Meurice, N., Petit, J. L., Polito, A., Caulfield, T. R., Castle, E. P., Copland, J. A., Mukhopadhyay, D., Pal, K., Dutta, S. K., Luo, H., Ho, T. H. & Lake, D. F., Jan 1 2020, In : Molecular cancer therapeutics. 19, 1, p. 112-122 11 p.

Research output: Contribution to journalArticle

Growth
Neoplasms
sulfhydryl oxidase
Enzyme Assays
Renal Cell Carcinoma
6 Citations (Scopus)

3D porous chitosan-alginate scaffold stiffness promotes differential responses in prostate cancer cell lines

Xu, K., Ganapathy, K., Andl, T., Wang, Z., Copland, J. A. III., Chakrabarti, R. & Florczyk, S. J., Oct 1 2019, In : Biomaterials. 217, 119311.

Research output: Contribution to journalArticle

Alginate
Chitosan
Scaffolds
Prostatic Neoplasms
Cells
5 Citations (Scopus)

Aberrant lipid metabolism as a therapeutic target in liver cancer

Pope, E. D., Kimbrough, E. O., Vemireddy, L. P., Surapaneni, P. K., Copland, J. A. III. & Mody, K., Jun 3 2019, In : Expert opinion on therapeutic targets. 23, 6, p. 473-483 11 p.

Research output: Contribution to journalArticle

Liver Neoplasms
Lipid Metabolism
Liver
Hepatocellular Carcinoma
Fatty Acids
9 Citations (Scopus)

Comprehensive genetic characterization of human thyroid cancer cell lines: A validated panel for preclinical studies

Landa, I., Pozdeyev, N., Korch, C., Marlow, L. A., Smallridge, R. C., Copland, J. A. III., Henderson, Y. C., Lai, S. Y., Clayman, G. L., Onoda, N., Tan, A. C., Garcia-Rendueles, M. E. R., Knauf, J. A., Haugen, B. R., Fagin, J. A. & Schweppe, R. E., Jan 1 2019, In : Clinical Cancer Research. 25, 10, p. 3141-3151 11 p.

Research output: Contribution to journalArticle

Medical Genetics
Thyroid Neoplasms
Cell Line
Neoplasms
Mutation
2 Citations (Scopus)

Pomalidomide alters pancreatic macrophage populations to generate an immune-responsive environment at precancerous and cancerous lesions

Bastea, L. I., Liou, G. Y., Pandey, V., Fleming, A. K., Von Roemeling, C. A., Doeppler, H., Li, Z., Qiu, Y., Edenfield, B., Copland, J. A. III., Tun, H. W. & Storz, P., Apr 1 2019, In : Cancer Research. 79, 7, p. 1535-1548 14 p.

Research output: Contribution to journalArticle

Open Access
Macrophages
Pancreatic Neoplasms
Population
Immunosuppressive Agents
Neoplasms